drug
calcifediol ER
Marketedupdated 5mo agoby OPKO Pharmaceuticals LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying calcifediol ER
- phase2Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
- N/APharmacokinetics of Calcifediol and Cholecalciferol
- phase2Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19
- phase3Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D Deficiency
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 2, 2027
121 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (16)
- Mar 14, 2034formulationUS 10300078
- Mar 14, 2034formulationUS 10357502
- Mar 14, 2034formulationUS 11253528
- Mar 14, 2034formulationUS 9861644
- Sep 7, 2030formulationUS 118012533.9y
- Aug 27, 2028method-of-use (U-1872)US 84263911.9y
- Jul 19, 2028formulationUS 83614881.8y
- Apr 25, 2028method-of-use (U-3815)US 111545091.6y
- Apr 25, 2028method-of-use (U-1871)US 82071491.6y
- Apr 25, 2028method-of-use (U-1873)US 87783731.6y
- Apr 25, 2028method-of-use (U-1888)US 94088581.6y
- Apr 25, 2028method-of-use (U-3814)US 94984861.6y
- Apr 25, 2028formulationUS 99251471.6y
- Feb 2, 2027formulationUS 10213442121d
- Feb 2, 2027formulationUS 8906410121d
- Feb 2, 2027method-of-use (U-2274)US 9943530121d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that